Trimeric peptides for antisense delivery
US-2021290772-A1 · Sep 23, 2021 · US
US12564636B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12564636-B2 |
| Application number | US-202318106242-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2023 |
| Priority date | Mar 26, 2022 |
| Publication date | Mar 3, 2026 |
| Grant date | Mar 3, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are pnictogen-containing heterocyclic compounds of Formula (I) Each of R1, the heterocyclic ring H, A+, LG, and X− is defined herein. Also provided are methods of modifying a substrate using such a compound, conjugated biomolecules thus modified, and pharmaceutical compositions containing one of the conjugated biomolecules.
Opening claim text (preview).
What is claimed is: 1 . A pnictogen-containing heterocyclic compound of Formula (I): in which R 1 is C 1 -C 6 alkyl, C4-C10 cycloalkyl, 5- to 8-membered heterocycloalkyl, aryl, or heteroaryl; is a heterocyclic ring; A + is a cationic quaternary pnictogen atom; LG is a leaving group selected from the group consisting of halogen, aryloxy, R a O 2 S—, R b O 2 S—O—, R c OS—, R d S(O)(NSO 2 R e )—, and R f S(O)(N + (CH 3 ) 2 )-, each of R a , R b , R c , R d , R e , and R f , independently, being C 1 -C 6 alkyl, aryl, heteroaryl, halogen, alkoxy, or aryloxy; X − is a counter anion selected from the group consisting of halide, polyhalide anion, perchlorate, hydroxide, peroxide, siloxide, sulfate, hydrogen sulfate, sulfite, disulfite, dithionate, dithionite, halosulfate, thiosulfate, persulfate, disulfate, sulfinate (R′SO 2 − ), sulfonate (R″SO 3 − ), bis(sulfonyl)imide ((R′SO 2 ) 2 N − ), nitrate, nitrite, azide, cyanide, cyanate, thiocyanate, phosphate, metaphosphate, polyphosphate, hydrogen phosphate, dihydrogen phosphate, monohalophosphate, dihalophosphate, hexahalophosphate, organophosphonate (R′P(O)(O − ) 2 or R′P(O)(OR − ) (O − )), organophosphate (R′OP(O)(O) 2 or R′OP(O)(OR″)(O − )), arsenate, alkoxide, alkenoxide, aryloxide, carboxylate, percarboxylate, carbonate, bicarbonate, oxalate, borate, tetrahaloborate, tetraalkylborate, tetraarylborate, carborane, and combinations thereof, each of R′ and R″, independently, being C 1 -C 6 alkyl or aryl; and the number of net negative charges of X″ equals to that of the net positive charges of 2 . The pnictogen-containing heterocyclic compound of claim 1 , wherein the compound is a compound of Formula (II): in which the cationic quaternary pnictogen atom is N + in Formula (II); R 1 is CH 3 , CH 2 CH 3 or -L-Het + ; each of R 2 , R 3 , R 4 , R 5 , and R 6 , independently, is H, F, Cl, Br, I, C 1 -C 10 alkoxy, R a O 2 S—, R b O 2 S—O—, R f S(O)(N + (CH 3 ) 2 )—, halogenated aryl, halogenated heteroaryl, Het + , or -L-Het + , in which Het + is R 1 ′ is CH 3 or CH 2 CH 3 ; each of R 2 ′, R 3 ′, R 4 ′, R 5 ′, and R 6 ′, independently, is H, NO 2 , F, Cl, Br, I, R a ′O 2 S—, R b ′O 2 S—O—, or R f S(O)(N + (CH 3 ) 2 )—; each of R a ′, R b ′, and R f ′, independently, is C 1 -C 6 alkyl or aryl; and X′ is a counter anion selected from the group consisting of halide, polyhalide anion, perchlorate, hydroxide, peroxide, siloxide, sulfate, hydrogen sulfate, sulfite, disulfite, dithionate, dithionite, halosulfate, thiosulfate, persulfate, disulfate, sulfinate (R′SO 2 − ), sulfonate (R″SO 3 − ), bis(sulfonyl)imide ((R′SO 2 ) 2 N − ), nitrate, nitrite, azide, cyanide, cyanate, thiocyanate, phosphate, metaphosphate, polyphosphate, hydrogen phosphate, dihydrogen phosphate, monohalophosphate, dihalophosphate, hexahalophosphate, organophosphonate (R′P(O)(O − ) 2 or R′P(O)(OR″)(O − )), organophosphate (R′OP(O)(O − ) 2 or R′OP(O)(OR″)(O − )), arsenate, alkoxide, alkenoxide, aryloxide, carboxylate, percarboxylate, carbonate, bicarbonate, oxalate, borate, tetrahaloborate, tetraalkylborate, tetraarylborate, carborane, and combinations thereof, each of R′ and R″, independently, being C 1 -C 6 alkyl or aryl; L is a linker selected from the group consisting of n is an integer from 0 to 20; R g is C 1 -C 6 alkyl; and Ar is aryl; at least one of R 2 , R 3 , R 4 , R 5 , and R 6 is the leaving group that is F, Cl, Br, I, R a O 2 S—, or R b O 2 S—O—; when R 2 is F, (i) R 4 is F, Cl, Br, I, C 1 -C 10 alkoxy, R a O 2 S—, or R b O 2 S—O—, (ii) R 5 is NO 2 , or (iii) one and only one of R 3 , R 4 , R 5 , and R 6 is Het + ; when R 2 is Cl, R 5 is H or Het + ; and when R 4 is-SO 2 CH 3 , (i) R 2 is F, Cl, Br, I, C 1 -C 10 alkoxy, R a O 2 S—, or R b O 2 S—O—, or (ii) one and only one of R 2 , R 3 , R 5 , and R 6 is Het + . 3 . The pnictogen-containing heterocyclic compound of claim 2 , wherein at least one of R 2 , R 4 , and R 6 is the leaving group. 4 . The pnictogen-containing heterocyclic compound of claim 3 , wherein the leaving group is F or CH 3 O 2 S—. 5 . The pnictogen-containing heterocyclic compound of claim 2 , wherein R 2 , being the leaving group, is CH 3 O 2 S—, and R 4 is H, C 1 -C 10 alkoxy, or Het + . 6 . The pnictogen-containing heterocyclic compound of claim 2 , wherein R 1 is methyl or ethyl. 7 . The pnictogen-containing heterocyclic compound of claim 2 , wherein R 3 or R 5 is NO 2 . 8 . The pnictogen-containing heterocyclic compound of claim 2 , wherein the compound is a compound of Formula (III): in which one and only one of B, D, and E is N + CH 3 or N + CH 2 CH 3 ; one and only one of B, D, and E is CR 2 , R 2 being F, Cl, Br, I, R a O 2 S—, or R b O 2 S—O—; one and only one of B, D, and E is CR 11 , R 11 being C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl amino, C 4 -C 10 cycloalkyl, C 4 -C 10 cycloalkoxy, 5- to 8-membered heterocycloalkyl, 5- to 8-membered heterocycloalkoxy, aryl, aryloxy, heteroaryl, or heteroaryloxy; one and only one of B′, D′, and E′ is N + CH 3 or N + CH 2 CH 3 ; one and only one of B′, D′, and E′ is CR 2 ′, R 2 ′ being F, Cl, Br, I, R a ′O 2 S—, or R b ′O 2 S—O—; one and only one of B′, D′, and E′ is CR 11 ′, R 11 ′ being C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 1 -C 6 alkyl amino, C 4 -C 10 cycloalkyl, C 4 -C 10 cycloalkoxy, 5- to 8-membered heterocycloalkyl, 5- to 8-membered heterocycloalkoxy, aryl, aryloxy, heteroaryl, or heteroaryloxy; and X′ − is a counter anion selected from the group consisting of halide, polyhalide anion, perchlorate, hydroxide, peroxide, siloxide, sulfate, hydrogen sulfate, sulfite, disulfite, dithionate, dithionite, halosulfate, thiosulfate, persulfate, disulfate, sulfinate (R′SO 2 − ), sulfonate (R″SO 3 − ), bis(sulfonyl)imide ((R′SO 2 ) 2 N − ), nitrate, nitrite, azide, cyanide, cyanate, thiocyanate, phosphate, metaphosphate, polyphosphate, hydrogen phosphate, dihydrogen phosphate, monohalophosphate, dihalophosphate, hexahalophosphate, organophosphonate (R′P(O)(O − ) 2 or R′P(O)(OR″)(O − )), organophosphate (R′OP(O)(O − ) 2 or R′OP(O)(OR″)(O − )), arsenate, alkoxide, alkenoxide, aryloxide, carboxylate, percarboxylate, carbonate, bicarbonate, oxalate, borate, tetrahaloborate, tetraalkylborate, tetraarylborate, carborane, and combinations thereof, each of R′ and R″, independently, being C 1 -C 6 alkyl or aryl. 9 . The pnictogen-containing heterocyclic compound of claim 8 , wherein each of R 2 and R 2 ′, independently, is F or CH 3 O 2 S—. 10 . The pnictogen-containing heterocyclic compound of claim 1 , wherein the compound is a compound of Formula (IV):
Benzothiazoles · CPC title
Halogen atoms or nitro radicals · CPC title
Halogen atoms or nitro radicals · CPC title
Sulfur atoms · CPC title
with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.